LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Open Monoclonal Technology Inc.
Headquarters:
Palo Alto, CA, United States of America
Website:
N/A
Year Founded:
2007
Status:
Acquired
BioCentury
|
Sep 1, 2017
Finance
Armo's China network
Why Armo brought Chinese investors on board for its $67M series C-1 round
Read More
BioCentury
|
Sep 1, 2017
Financial News
Armo raises $67M series C-1 round
Read More
BioCentury
|
Aug 29, 2017
Financial News
Armo raises $67M series C-1 round
Read More
BioCentury
|
Jul 25, 2016
Company News
Open Monoclonal Technology, WuXi PharmaTech deal
Read More
BioCentury
|
Feb 15, 2016
Finance
Combo collector
Why investors bought into Armo's immunotherapy combo strategy
Read More
BioCentury
|
Dec 7, 2015
Company News
Open Monoclonal Technology, Seattle Genetics deal
Read More
BioCentury
|
Nov 16, 2015
Company News
Open Monoclonal Technology, Armo BioSciences deal
Read More
BioCentury
|
Oct 26, 2015
Company News
Open Monoclonal Technology, Five Prime deal
Read More
BioCentury
|
Jul 13, 2015
Company News
Open Monoclonal Technology, Amgen deal
Read More
BioCentury
|
Mar 30, 2015
Company News
Open Monoclonal Technology, Celgene deal
Read More
Items per page:
10
1 - 10 of 27